Philadelphia gene therapy startup raises $75M

Philadelphia gene therapy startup Limelight Bio, whose founders include researchers from the University of Pennsylvania Perelman School of Medicine and Children's Hospital of Philadelphia, has raised $75 million in venture capital financing. The investment in Limelight was made by Apple Tree Partners, a life sciences innovation fund based in New York City that also provided seed funding to launch Limelight in late 2016. Limelight is developing proprietary technologies designed to overcome limitations…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news